• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    ConocoPhillips To Rally Over 30%? Here Are 10 Other Price Target Changes For Wednesday

    12/7/22 7:46:24 AM ET
    $ABNB
    $AZO
    $COP
    $ESS
    Diversified Commercial Services
    Consumer Discretionary
    Auto & Home Supply Stores
    Consumer Discretionary
    Get the next $ABNB alert in real time by email
    • Barclays raised ConocoPhillips (NYSE:COP) price target from $135 to $151. Barclays analyst Jeanine Wai maintained an Overweight rating on the stock. ConocoPhillips shares fell 3.2% to close at $115.61 on Tuesday.
    • Keybanc cut Essex Property Trust, Inc. (NYSE:ESS) price target from $314 to $240. Keybanc analyst Austin Wurschmidt maintained an Overweight rating on the stock. Essex Property Trust fell 0.5% to $210.00 in pre-market trading.
    • Piper Sandler lowered the price target on Skillsoft Corp. (NYSE:SKIL) from $2.5 to $2.3. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating on the stock. Skillsoft shares fell 4.5% to close at $1.91 on Tuesday.
    • SVB Leerink cut Gossamer Bio, Inc. (NASDAQ:GOSS) price target from $15 to $10. SVB Leerink analyst Joseph Schwartz maintained an Outperform rating on the stock. Gossamer Bio shares fell 4.7% to $2.25 in pre-market trading.
    • Morgan Stanley cut Airbnb, Inc. (NASDAQ:ABNB) price target from $110 to $80. Morgan Stanley analyst Brian Nowak downgraded the stock from Equal-Weight to Underweight. Airbnb shares dropped 4% to $89.42 in pre-market trading.
    • Keefe, Bruyette & Woods lowered M&T Bank Corporation (NYSE:MTB) price target from $215 to $180. Keefe, Bruyette & Woods analyst David Konrad downgraded the stock from Outperform to Market Perform. M&T Bank shares fell 1.2% to $158.50 in pre-market trading.
    • Telsey Advisory Group raised Signet Jewelers Limited (NYSE:SIG) price target from $72 to $75. Telsey Advisory Group analyst Dana Telsey maintained the stock with a Market Perform. Signet Jewelers Limited shares fell 0.8% to $69.00 in pre-market trading.
    • Goldman Sachs cut Sema4 Holdings Corp. (NASDAQ:SMFR) price target from $3 to $1. Goldman Sachs analyst Matthew Sykes downgraded the stock from Buy to Neutral. Sema4 Holdings shares gained 5.3% to $0.3185 in pre-market trading.
    • Needham cut MongoDB, Inc. (NASDAQ:MDB) price target from $330 to $225. Needham analyst Mike Cikos maintained a Buy rating on the stock. MongoDB shares jumped 26% to $182.40 in pre-market trading.
    • Raymond James raised AutoZone, Inc. (NYSE:AZO) price target from $2,500 to $2,600. Raymond James analyst Bobby Griffin maintained an Outperform rating on the stock. AutoZone shares fell 0.3% to $2,450.00 in pre-market trading.
    • Baird cut Wejo Group Limited (NASDAQ:WEJO) price target from $3 to $1.5. Baird analyst Jeffrey Meuler downgraded the stock from Outperform to Neutral. Wejo Group shares fell 7.1% to close at $0.7878 on Tuesday.

    Check out this: Meta Platforms Shares Plunged On Tuesday; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

    Get the next $ABNB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABNB
    $AZO
    $COP
    $ESS

    CompanyDatePrice TargetRatingAnalyst
    Gossamer Bio Inc.
    $GOSS
    2/24/2026$1.00Outperform → Neutral
    Wedbush
    Gossamer Bio Inc.
    $GOSS
    2/24/2026$0.30Overweight → Equal Weight
    Barclays
    Gossamer Bio Inc.
    $GOSS
    2/24/2026$1.00Outperform → Market Perform
    Leerink Partners
    ConocoPhillips
    $COP
    2/17/2026$112.00Buy → Neutral
    Roth Capital
    Airbnb Inc.
    $ABNB
    2/13/2026$145.00In-line → Outperform
    Evercore ISI
    Airbnb Inc.
    $ABNB
    2/13/2026$154.00Hold → Buy
    Deutsche Bank
    AutoZone Inc.
    $AZO
    2/9/2026$3900.00Outperform → Neutral
    Robert W. Baird
    Airbnb Inc.
    $ABNB
    2/4/2026$160.00Mkt Perform → Mkt Outperform
    Citizens JMP
    More analyst ratings

    $ABNB
    $AZO
    $COP
    $ESS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Gossamer Bio downgraded by Wedbush with a new price target

    Wedbush downgraded Gossamer Bio from Outperform to Neutral and set a new price target of $1.00

    2/24/26 8:01:18 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gossamer Bio downgraded by Barclays with a new price target

    Barclays downgraded Gossamer Bio from Overweight to Equal Weight and set a new price target of $0.30

    2/24/26 7:42:57 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gossamer Bio downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded Gossamer Bio from Outperform to Market Perform and set a new price target of $1.00

    2/24/26 7:42:57 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABNB
    $AZO
    $COP
    $ESS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director George Michael A bought $492,729 worth of shares (145 units at $3,398.13), increasing direct ownership by 34% to 566 units (SEC Form 4)

    4 - AUTOZONE INC (0000866787) (Issuer)

    12/22/25 5:06:23 PM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    Director Hannasch Brian bought $498,784 worth of shares (147 units at $3,393.09), increasing direct ownership by 18% to 962 units (SEC Form 4)

    4 - AUTOZONE INC (0000866787) (Issuer)

    12/19/25 4:52:15 PM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    CFO Jackson Jamere bought $187,742 worth of shares (55 units at $3,413.50), increasing direct ownership by 13% to 488 units (SEC Form 4)

    4 - AUTOZONE INC (0000866787) (Issuer)

    12/12/25 5:56:41 PM ET
    $AZO
    Auto & Home Supply Stores
    Consumer Discretionary

    $ABNB
    $AZO
    $COP
    $ESS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension

    - Seralutinib demonstrated a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of +13.3 meters at Week 24 (p = 0.0320), missing the prespecified alpha threshold of 0.025 - - At week 24, patients receiving seralutinib had a median change of +28.2 meters from baseline, while patients receiving placebo had a median change from baseline of +13.5 meters - - Consistent with the TORREY Study, prespecified intermediate and high-risk subgroup (n = 234) showed a +20.0 meter placebo-adjusted 6MWD improvement (p = 0.0207), with 3 of 4 key secondary endpoints achieving p < 0.0125 - - Overall treatment effect was most pronounced in North America (n = 75), with a +25.9m placebo-adjuste

    2/23/26 8:00:00 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Skillsoft Announces New Employee Inducement Grant Under NYSE Rule 303A.08

    Skillsoft (NYSE:SKIL) ("Skillsoft" or the "Company"), the leading AI-native skills management platform built for the human + AI era, today announced that on February 18, 2026, the Talent and Compensation Committee of Skillsoft's Board of Directors (the "Committee") made a grant of 95,000 restricted stock units ("RSUs") of the Company's Class A common stock to Bernard Barbour. The grant of RSUs was offered as a material inducement to Mr. Barbour's hiring as Chief Technology and Product Officer on December 8, 2025, and was made under Skillsoft's 2024 Employment Inducement Incentive Award Plan, as amended. Half (50%) of such RSUs vest ratably over four years; and the remaining 50% represent a

    2/20/26 5:30:00 PM ET
    $SKIL
    Computer Software: Prepackaged Software
    Technology

    Essex Announces its 32nd Consecutive Annual Dividend Increase

    Establishes Record Date for the Annual Shareholders' Meeting Essex Property Trust, Inc. (NYSE:ESS) announced today that its Board of Directors has approved a 0.8% increase to its annual cash dividend. This represents the Company's 32nd consecutive annual dividend increase. The Board of Directors has declared a first quarter dividend of $2.59 per share, payable April 15, 2026 to shareholders of record as of March 31, 2026. On an annualized basis, the dividend represents a distribution of $10.36 per common share. The Annual Meeting of Shareholders will be held virtually on Tuesday, May 12, 2026 at 10:00 a.m. Pacific Time or 1:00 p.m. Eastern Time. Shareholders of record as of February 25,

    2/19/26 4:15:00 PM ET
    $ESS
    Real Estate Investment Trusts
    Real Estate

    $ABNB
    $AZO
    $COP
    $ESS
    SEC Filings

    View All

    Gossamer Bio Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Gossamer Bio, Inc. (0001728117) (Filer)

    2/23/26 8:30:24 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by M&T Bank Corporation

    10-K - M&T BANK CORP (0000036270) (Filer)

    2/18/26 1:04:08 PM ET
    $MTB
    Major Banks
    Finance

    SEC Form 144 filed by MongoDB Inc.

    144 - MongoDB, Inc. (0001441816) (Subject)

    2/17/26 3:15:06 PM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    $ABNB
    $AZO
    $COP
    $ESS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO and Chairman Chesky Brian converted options into 255,140 shares (SEC Form 4)

    4 - Airbnb, Inc. (0001559720) (Issuer)

    2/24/26 7:00:03 PM ET
    $ABNB
    Diversified Commercial Services
    Consumer Discretionary

    Chief Strategy Officer Blecharczyk Nathan sold $533,735 worth of shares (4,260 units at $125.29), decreasing direct ownership by 8% to 49,250 units (SEC Form 4)

    4 - Airbnb, Inc. (0001559720) (Issuer)

    2/24/26 5:30:50 PM ET
    $ABNB
    Diversified Commercial Services
    Consumer Discretionary

    Chief Strategy Officer Blecharczyk Nathan covered exercise/tax liability with 2,458 shares and converted options into 400 shares, decreasing direct ownership by 4% to 53,510 units (SEC Form 4)

    4 - Airbnb, Inc. (0001559720) (Issuer)

    2/23/26 8:13:13 PM ET
    $ABNB
    Diversified Commercial Services
    Consumer Discretionary

    $ABNB
    $AZO
    $COP
    $ESS
    Leadership Updates

    Live Leadership Updates

    View All

    Airbnb Announces Fourth Quarter and Full Year 2025 Results

    SAN FRANCISCO, Feb. 12, 2026 /PRNewswire/ -- Airbnb, Inc. (NASDAQ:ABNB) has posted a shareholder letter containing its fourth quarter and full year 2025 financial results on its Investor Relations website at https://investors.airbnb.com. Airbnb will host an audio webcast to discuss its results at 2:00 p.m. PT / 5:00 p.m. ET today. The link to the webcast will be made available on the Investor Relations website at https://investors.airbnb.com. Interested parties can register for the call in advance by visiting https://registrations.events/direct/Q4I66365458. After registering,

    2/12/26 4:03:00 PM ET
    $ABNB
    Diversified Commercial Services
    Consumer Discretionary

    M&T Bank Appoints Jeff Carpenter Regional President for Massachusetts

    Industry veteran brings 20+ years of expertise to drive growth, reinforce commitment to customer service and lead community engagement BOSTON, Feb. 2, 2026 /PRNewswire/ -- M&T Bank (NYSE: MTB) today announced the appointment of Jeff Carpenter as its new Regional President of Massachusetts. With more than two decades of corporate and specialty banking experience, Carpenter brings deep regional knowledge, financial expertise and a strong record of leadership to this role, reinforcing M&T's commitment to delivering exceptional service to its customers. Carpenter has served as Executive Vice President, Head of Specialty and Corporate Banking since 2023. In his expanded role as Regional President

    2/2/26 7:05:00 AM ET
    $MTB
    Major Banks
    Finance

    Skillsoft Appoints Bernard Barbour as Chief Technology and Product Officer

    Proven technology leader brings expertise in AI, cloud platforms, and enterprise SaaS to advance Skillsoft's next-generation skills management platform Today, Skillsoft (NYSE:SKIL), the leading AI-native skills management platform built for the human + AI era, announced Bernard Barbour has joined Skillsoft as Chief Technology and Product Officer. In this role, Mr. Barbour will lead the continued evolution of the Skillsoft Percipio Platform as a unified skills management system that connects skills, learning, and workforce capability to business needs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115719140/en/Bernard Barbo

    1/15/26 8:30:00 AM ET
    $SKIL
    Computer Software: Prepackaged Software
    Technology

    $ABNB
    $AZO
    $COP
    $ESS
    Financials

    Live finance-specific insights

    View All

    Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension

    - Seralutinib demonstrated a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of +13.3 meters at Week 24 (p = 0.0320), missing the prespecified alpha threshold of 0.025 - - At week 24, patients receiving seralutinib had a median change of +28.2 meters from baseline, while patients receiving placebo had a median change from baseline of +13.5 meters - - Consistent with the TORREY Study, prespecified intermediate and high-risk subgroup (n = 234) showed a +20.0 meter placebo-adjusted 6MWD improvement (p = 0.0207), with 3 of 4 key secondary endpoints achieving p < 0.0125 - - Overall treatment effect was most pronounced in North America (n = 75), with a +25.9m placebo-adjuste

    2/23/26 8:00:00 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Essex Announces its 32nd Consecutive Annual Dividend Increase

    Establishes Record Date for the Annual Shareholders' Meeting Essex Property Trust, Inc. (NYSE:ESS) announced today that its Board of Directors has approved a 0.8% increase to its annual cash dividend. This represents the Company's 32nd consecutive annual dividend increase. The Board of Directors has declared a first quarter dividend of $2.59 per share, payable April 15, 2026 to shareholders of record as of March 31, 2026. On an annualized basis, the dividend represents a distribution of $10.36 per common share. The Annual Meeting of Shareholders will be held virtually on Tuesday, May 12, 2026 at 10:00 a.m. Pacific Time or 1:00 p.m. Eastern Time. Shareholders of record as of February 25,

    2/19/26 4:15:00 PM ET
    $ESS
    Real Estate Investment Trusts
    Real Estate

    Signet Jewelers Announces Timing of Fiscal 2026 Fourth Quarter Earnings Release and Conference Call

    Signet Jewelers Limited (NYSE:SIG) intends to announce its fourth quarter results at approximately 7:00 a.m. ET on Thursday, March 19, 2026. On that date there will be a conference call at 8:00 a.m. ET and a simultaneous audio webcast available at www.signetjewelers.com. The call details are: Toll Free – North America (+1) 800 549 8228 International All Other Location: (Toll - Local - New York) - (+1) 646 564 2877 Conference ID 21035 Registration for the listen-only webcast is available at the following link: https://events.q4inc.com/attendee/340662140 About Signet: Signet operates eCommerce sites and approximately 2,600 stores under the name brands KAY Jewelers, Zales, Ja

    2/19/26 7:30:00 AM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    $ABNB
    $AZO
    $COP
    $ESS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by MongoDB Inc.

    SC 13G/A - MongoDB, Inc. (0001441816) (Subject)

    11/15/24 10:35:42 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Gossamer Bio Inc.

    SC 13G/A - Gossamer Bio, Inc. (0001728117) (Subject)

    11/12/24 4:40:26 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by M&T Bank Corporation

    SC 13G - M&T BANK CORP (0000036270) (Subject)

    11/12/24 10:32:14 AM ET
    $MTB
    Major Banks
    Finance

    $ABNB
    $AZO
    $COP
    $ESS
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care